Skip to content
Menu

Lake Street Initiates Coverage On Pelthos Therapeutics with Buy Rating, Announces Price Target of $50

Benzinga Newsdesk 11 months ago

NewsPrice TargetInitiationAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Lake Street analyst Thomas Flaten initiates coverage on Pelthos Therapeutics (AMEX:PTHS) with a Buy rating and announces Price Target of $50.

Lake Street analyst Thomas Flaten initiates coverage on Pelthos Therapeutics (AMEX:PTHS) with a Buy rating and announces Price Target of $50.

Read at benzinga.com